State Street’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.7M Buy
1,019,850
+92,612
+10% +$1.33M ﹤0.01% 2357
2025
Q1
$6.4M Buy
927,238
+12,263
+1% +$84.6K ﹤0.01% 2775
2024
Q4
$4.85M Buy
914,975
+296,947
+48% +$1.58M ﹤0.01% 2997
2024
Q3
$2.26M Buy
618,028
+62,692
+11% +$229K ﹤0.01% 3288
2024
Q2
$1.52M Buy
555,336
+365,097
+192% +$997K ﹤0.01% 3404
2024
Q1
$662K Hold
190,239
﹤0.01% 3573
2023
Q4
$272K Hold
190,239
﹤0.01% 3814
2023
Q3
$278K Hold
190,239
﹤0.01% 3840
2023
Q2
$299K Hold
190,239
﹤0.01% 3871
2023
Q1
$291K Buy
190,239
+13,400
+8% +$20.5K ﹤0.01% 3937
2022
Q4
$297K Hold
176,839
﹤0.01% 3946
2022
Q3
$218K Sell
176,839
-60,260
-25% -$74.3K ﹤0.01% 4099
2022
Q2
$396K Sell
237,099
-695,427
-75% -$1.16M ﹤0.01% 3929
2022
Q1
$2.29M Buy
932,526
+36,308
+4% +$89.3K ﹤0.01% 3509
2021
Q4
$3.35M Buy
896,218
+10,855
+1% +$40.6K ﹤0.01% 3439
2021
Q3
$5.55M Buy
885,363
+50,720
+6% +$318K ﹤0.01% 3181
2021
Q2
$8.23M Buy
834,643
+106,207
+15% +$1.05M ﹤0.01% 3010
2021
Q1
$6.8M Buy
728,436
+14,490
+2% +$135K ﹤0.01% 2919
2020
Q4
$3.43M Sell
713,946
-11,644
-2% -$55.9K ﹤0.01% 3145
2020
Q3
$2.91M Sell
725,590
-5,392
-0.7% -$21.6K ﹤0.01% 3050
2020
Q2
$3.36M Buy
730,982
+32,560
+5% +$149K ﹤0.01% 2959
2020
Q1
$2.28M Buy
698,422
+16,124
+2% +$52.6K ﹤0.01% 3004
2019
Q4
$2.94M Buy
682,298
+81,755
+14% +$352K ﹤0.01% 3098
2019
Q3
$2.36M Buy
600,543
+17,296
+3% +$68.1K ﹤0.01% 3157
2019
Q2
$2.71M Buy
583,247
+24,045
+4% +$112K ﹤0.01% 3121
2019
Q1
$2.34M Buy
559,202
+4,060
+0.7% +$17K ﹤0.01% 3093
2018
Q4
$1.9M Sell
555,142
-10,746
-2% -$36.9K ﹤0.01% 3139
2018
Q3
$2.43M Buy
565,888
+35,236
+7% +$151K ﹤0.01% 3176
2018
Q2
$1.97M Buy
530,652
+506,392
+2,087% +$1.88M ﹤0.01% 3264
2018
Q1
$102K Buy
+24,260
New +$102K ﹤0.01% 3613
2017
Q2
Sell
-331,073
Closed -$891K 3745
2017
Q1
$891K Buy
331,073
+6,062
+2% +$16.3K ﹤0.01% 3295
2016
Q4
$1.08M Sell
325,011
-3,154
-1% -$10.5K ﹤0.01% 3260
2016
Q3
$974K Buy
328,165
+107,549
+49% +$319K ﹤0.01% 3202
2016
Q2
$913K Buy
+220,616
New +$913K ﹤0.01% 3295